Insider trade

Jazz Pharmaceuticals (JAZZ): Officer had shares withheld for tax 16 shares

Mary Elizabeth Henderson, Officer at Jazz Pharmaceuticals, reported a tax withholding of 16 shares.

16
Shares · @ $244.64
Traded
Aug 31, 2026
Filed
Sep 3, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

The company's last weighty Form 8-K report up to this date: signed an important agreement, 5 days earlier (Aug 26, 2026). The first one after it: signed an important agreement, 23 days later (Sep 23, 2026).

  1. InsiderDirector sold ~$1.44M of JAZZ shares in the open market
  2. Company filing · Form 8-K · ResultsReported its results
  3. InsiderDirector sold ~$1.52M of JAZZ shares in the open market
  4. Company filing · Form 8-K · Material agreementSigned an important agreement
  5. Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations (and 2 more items)
  6. Insider · 1 personInsiders: 6 sales (~$19.2M)

What came next

  1. InsiderDirector sold ~$1.5M of JAZZ shares in the open market
  2. InsiderCEO sold ~$486K of JAZZ shares in the open market
  3. InsiderOfficer sold ~$289K of JAZZ shares in the open market
  4. Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
  5. InsiderDirector sold ~$1.38M of JAZZ shares in the open market
  6. Company filing · Form 8-K · Executive changeChanged a top executive or board member“On October 6, 2026, Samantha Pearce, Executive Vice President, Chief Commercial Officer of Jazz Pharmaceuticals plc (the “Company” ), notified the Company of her intent to retire from her role as Chief Commercial Officer upon the earlier of the selection and appointment of her successor or by June 30, 2027.”
  7. InsiderCEO sold ~$473K of JAZZ shares in the open market
  8. Company filing · Form 8-K · ResultsReported its results
  9. Company filing · Form 8-K · ResultsReported its results
  10. InsiderDirector sold ~$1.3M of JAZZ shares in the open market
  11. InsiderCEO sold ~$225K of JAZZ shares in the open market
  12. Insider · 1 personInsiders: 2 sales (~$327K)
  13. 5% stakeFMR LLC reported a passive stake (13G) of 8.6%
  14. Insider · 1 personInsiders: 4 sales (~$16.2M)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Jazz Pharmaceuticals

For Jazz Pharmaceuticals, OQRO holds 25 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JAZZ page.

Other recent filings by Mary Elizabeth Henderson, SVP, Technical Operations

The full history of Mary Elizabeth Henderson, SVP, Technical Operations is on the profile page.

How this filing works

Explore the data

Common questions

Which Jazz Pharmaceuticals (JAZZ) insider traded, and how much?

Mary Elizabeth Henderson, Officer at Jazz Pharmaceuticals, reported a tax withholding of 16 shares. At $244.64.

When did it happen, and when was it made public?

Traded: Aug 31, 2026. Filed: Sep 3, 2026. That is 3 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Jazz Pharmaceuticals recently?

For Jazz Pharmaceuticals, OQRO holds 25 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the JAZZ page.

Does this mean JAZZ stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Jazz Pharmaceuticals

Everything OQRO holds on this company is on its JAZZ page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data